ILMN Stock Discussion

Illumina, Inc. Description

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. Its sequencing platforms include HiSeq 2000, an instrument for high-throughput sequencing using sequencing by synthesis (SBS) technology; HiSeq 1500 that accommodates lower throughput needs; and MiSeq Personal Sequencing System that offers sequencing applications in a compact and economical instrument for individual researchers. The company's sequencing/array combination platforms comprise HiScanSQ that combines SBS technology and HiScan microarray analysis instrumentation into one system. Its array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of its array-based genetic analysis products. The company also offers various sample preparation and sequencing kits, such as standard sequencing kits; Infinium assay kits; paired-end genomic deoxyribonucleic acid (DNA) sample prep kits; and TruSeq SBS sequencing kits, as well as library preparation kits. In addition, it provides InfiniumHD Whole-Genome BeadChips, which are multi-sample DNA analysis microarrays; HumanOmni5-Quad, HumanOmni2.5, and HumanOmni1S BeadChips; agriculturally relevant genome panels; and iSelect Custom Genotyping BeadChips. Further, it offers CytoChip, a test for the investigation of genetic abnormalities associated with developmental delay or with complex leukemia's; Eco Real-Time polymerase chain reaction system; and sequencing and genotyping services. The company serves genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agri-genomics, and consumer genomics companies. It sells its products directly and through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Biotechnology Life Sciences Biology Nasdaq 100 Acid Imaging Telehealth Molecular Biology Telemedicine Genomics Clinical Research Lab Testing Scanner Genome DNA Sequencing Polymerase Chain Reaction Genotyping Life Science Tools